The International MAOI Expert Group unites clinicians and researchers with specific expertise in the pharmacology and clinical use of the classic monoamine oxidase inhibitor (MAOI) antidepressants (phenelzine, tranylcypromine, isocarboxazid). The Group has recently authored two Prescriber’s Guides o...See more
Headquarters:
Australia
Company Type:
SME
Company size:
11-50 Employees
Year Founded:
2022 (4 years)
Address:
BUCASIA, QLD, AU
LOW
spending power
